Paasa Logo
Dong-A ST Co., Ltd. logo
170900KRXMarket closedOpens 9:00am KST

Dong-A ST Co., Ltd.

₩34,950.00Last updated
-₩450.00 (1.27%)Past day
Timezone

Dong-A ST Co., Ltd. (KRX: 170900) is trading at ₩34,950.00, about ₹2,522 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 1.27% today. Dong-A ST is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.

Quote

Open:₩35,200.00
Previous close:₩35,400.00
Volume:3.76K

Today's low

₩34,750.00

Today's high

₩35,650.00

52 week low

₩31,600.00

52 week high

₩59,200.00

170900 opened at ₩35,200.00, closed previously at ₩35,400.00, and has traded between ₩31,600.00 and ₩59,200.00 over the past 52 weeks.

About

Dong-A ST Co., Ltd. is a global enterprise focused on the research, development, production, and commercialization of a broad spectrum of pharmaceutical products and medical devices. The company's diverse portfolio of ethical drugs targets various medical conditions, including tuberculosis (with treatments like Closerin and Terizidone), neutropenia in chemotherapy patients (such as Dulastin and Leucostim), and anemia stemming from chronic renal failure (Eporon). Its robust oncology offerings feature Gemcit for cancers affecting the lung, pancreas, breast, bladder, and ovaries; Mainta for non-small cell lung cancer and malignant pleural mesothelioma; and Monotaxel, indicated for breast, prostate, head, neck, and gastric adenocarcinoma, among others. Additionally, Dong-A ST provides solutions for infertility and anovulation (Gonadopin), growth hormone deficiency and idiopathic short stature (Growtropin II), functional dyspepsia (Motilitone), gastritis (Stillen), diabetes (Suganon), and erectile dysfunction (Zydena). The company also actively participates in pharmaceutical licensing, encompassing both the acquisition and out-licensing of drugs. Its medical device segment includes advanced technological equipment, customized products, and specialized artificial cardiac circuit sets essential for complex open-heart surgeries. Dong-A ST Co., Ltd. was established in 1932 and is headquartered in Seoul, South Korea.

Country
KR
CEO
Jae-Hun Jung
Exchange listed on
KRX
Industry
Drug Manufacturers - Specialty & Generic
Base currency
KRW
Full Time Employees
1,685
Sector
Healthcare
IPO date
05/04/2013

Key statistics

Avg. volume

14.36K

Market cap

₩337.05B

P/E Ratio

-57.16

Price-to-sales ratio

0.39

Enterprise value

₩873.65B

Free cash flow yield

-2.02%

Debt-to-equity ratio

0.75

Return on equity

-4.45%

ROIC

0.05%

Beta

0.40

Dividend yield

2.00%

Last dividend

₩700.00

Financial overview

Revenue

₩808.79B

Earnings per share

-₩2,970.54

Free cash flow

-₩10.10B

Net profit margin

0.34%

Gross margin

43.66%

EBITDA

₩33.45B

Revenue growth

15.89%

Similar securities

This is not an investment recommendation

Dong-A ST for Indian investors

Dong-A ST is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.

Taxes on Dong-A ST for Indian residents

Trading and limits

Trading hours
9:00 am – 3:30 pm KST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Dong-A ST’s current yield is 2.00%.Dividend tax explained

FAQs

Can I buy Dong-A ST on Paasa?

Dong-A ST (170900) has been listed on the Korea Exchange since 2013, in the Drug Manufacturers - Specialty & Generic industry. Dong-A ST is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.

How much does one Dong-A ST share cost in rupees?

One Dong-A ST share is ₩34,950.00 — about ₹2,522 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Dong-A ST price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for investing abroad from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.

How are gains on Dong-A ST shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Dong-A ST price.

Does Dong-A ST pay a dividend, and how is it taxed in India?

Yes. Dong-A ST pays a dividend and the current yield is 2.00%; the last declared dividend was ₩700.00 per share, about ₹50.52. Dividends are taxed at your slab rate in India.

When does KRX trade, in Indian time?

The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.

Do I have to declare Dong-A ST shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.

Does the rupee rate affect what I make on Dong-A ST?

Yes. Dong-A ST is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.